Previous 10 | Next 10 |
Gainers: NLNK +14.3% . OTIC +5.2% . PD +4.1% . KNSL +3.0% . CLSD +2.9% . More news on: NewLink Genetics Corporation, Otonomy, Inc., PagerDuty, Inc., Stocks on the move, , News on ETFs Read more ...
Gainers: REVG +6.9% . MU +3.4% . PCG +2.2% . OBSV +2.8% . DERM +1.1% . More news on: REV Group, Inc., Micron Technology, Inc., PG&E Corporation, Stocks on the move, , News on ETFs Read more ...
I started studying price movement of uplisting stocks in early 2016 and shared my findings in this article and followed up with a deeper look in subsequent articles ( 1 , 2 , 3 ). Uplisting for the purpose of this discussion is when a stock moves from trading in the Over The Counter Market (...
CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the ...
LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45 AM PST/ 12:45 PM ET at the Luxe Sunset...
OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company...
OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000 convertible promissory note issued by Coeptis Pharmaceuticals, Inc., a biopharmaceutica...
OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm ® , one of the most advanced oral...
OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has appointed Dr. Vered Gigi as its chief scientific officer. In this role, Dr. Gigi will oversee all CURE’s research and development. Dr. Gigi ...
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. The deal gives CURE direct, guaranteed access to high-quality plant ...
News, Short Squeeze, Breakout and More Instantly...
Cure Pharmaceutical Holding Corp Company Name:
CURR Stock Symbol:
OTCMKTS Market:
New Initiatives Showing Encouraging Results SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended Dec...
Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and Facial Plastic Surgeon Dr. Michael Persky New TikTok Shop Ready for Launch to Help Grow Brand Awareness and Product Sales SHERMAN OAKS...
New Campaigns Showing Encouraging Results SHERMAN OAKS, CA / ACCESSWIRE / November 14, 2023 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the third fiscal quarter ended S...